Literature DB >> 18363488

Genetics assessment at the end of life: suggestions for implementation in clinic and future research.

John Martin Quillin1, Joann N Bodurtha, Thomas J Smith.   

Abstract

BACKGROUND: Approximately 5%-10% of all cancers and cardiovascular diseases have a significant genetic component. Of the 15 most frequent admission diagnoses for palliative care, at least one third have a significant genetic component which is testable, informative, and potentially life saving to the survivors. Once the patient has died, the chance to test or bank DNA for common inherited conditions such as breast cancer, colon cancer, cardiovascular disease, etc., is gone.
OBJECTIVE: To determine the frequency of genetic conditions for commonly seen palliative care conditions, the availability of testing or DNA banking for future testing, and how genetics assessment is helpful.
DESIGN: A case illustration and review of the currently published evidence.
RESULTS: Genetic testing fits the accepted model of family-centered palliative care, is ethical, and may lead to life-saving interventions. Risk assessment tools and helpful websites are available.
CONCLUSIONS: While common genetic conditions should be recognized before end-of-life care, the palliative care health professional may be the only person to recognize the condition before death of the patient and loss of available DNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363488     DOI: 10.1089/jpm.2007.0150

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  8 in total

1.  Physicians' current practices and opportunities for DNA banking of dying patients with cancer.

Authors:  John M Quillin; Joann N Bodurtha; Laura A Siminoff; Thomas J Smith
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

2.  High-Risk Palliative Care Patients' Knowledge and Attitudes about Hereditary Cancer Testing and DNA Banking.

Authors:  John M Quillin; Oluwabunmi Emidio; Brittany Ma; Lauryn Bailey; Thomas J Smith; In Guk Kang; Brandon J Yu; Oluwafemi Patrick Owodunni; Mohammed Abusamaan; Rab Razzak; Joann N Bodurtha
Journal:  J Genet Couns       Date:  2017-12-04       Impact factor: 2.537

3.  Exploring hereditary cancer among dying cancer patients--a cross-sectional study of hereditary risk and perceived awareness of DNA testing and banking.

Authors:  John Martin Quillin; Joann N Bodurtha; Laura A Siminoff; Thomas J Smith
Journal:  J Genet Couns       Date:  2010-08-03       Impact factor: 2.537

4.  A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges.

Authors:  Molly S Daniels; Jennifer K Burzawa; Amanda C Brandt; Kathleen M Schmeler; Karen H Lu
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

5.  Views and experiences of palliative care clinicians in addressing genetics with individuals and families: a qualitative study.

Authors:  Stephanie White; Jane Phillips; Erin Turbitt; Chris Jacobs
Journal:  Support Care Cancer       Date:  2021-09-22       Impact factor: 3.359

6.  Long-term whole blood DNA preservation by cost-efficient cryosilicification.

Authors:  Liang Zhou; Qi Lei; Jimin Guo; Yuanyuan Gao; Jianjun Shi; Hong Yu; Wenxiang Yin; Jiangfan Cao; Botao Xiao; Jacopo Andreo; Romy Ettlinger; C Jeffrey Brinker; Stefan Wuttke; Wei Zhu
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

7.  Mainstreaming genetics in palliative care: barriers and suggestions for clinical genetic services.

Authors:  A Dearing; N Taverner
Journal:  J Community Genet       Date:  2017-11-20

8.  Issues related to family history of cancer at the end of life: a palliative care providers' survey.

Authors:  Catherine Gonthier; Sylvie Pelletier; Pierre Gagnon; Ana Marin; Jocelyne Chiquette; Bruno Gagnon; Louis Roy; Jude Emmanuel Cléophat; Yann Joly; Michel Dorval
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.